Menopause Supplement Trial Launched by The Better Menopause
The company has initiated a clinical study to evaluate the effectiveness of its metabolism-focused supplement in women.
Updated on Sept. 22, 2026 in Weight Loss
Live Poll
Do you trust that health supplements marketed for menopause provide real, verified medical benefits?
The Better Menopause is investing £100,000 into a new clinical research project to examine its Better Metabolism supplement. This randomized, controlled trial involves 80-90 participants experiencing menopause.
Why it matters
This research initiative seeks to address the frequent lack of robust scientific evidence supporting many products marketed for women's health. By conducting this trial, the company aims to provide data to substantiate potential benefits for users.
Researchers at the University of Southampton are conducting a randomized, double-blind, placebo-controlled clinical trial involving 80-90 women in menopause. The study monitors outcomes over a 12-week intervention period, though definitive results remain pending publication next year.
The players
The Better Menopause
A company focused on health products for women that currently sells items in the UK, Ireland, US, Australia, and Canada.
University of Southampton
A public research institution providing researchers to lead the clinical investigation of the supplement.
Joanna Lyall
A founder of The Better Menopause.
Debbie Wosskow
A founder of The Better Menopause.
The details
The trial utilizes a standard design where participants are divided into groups to compare the supplement against a placebo. Researchers are collecting blood and urine samples at the start and conclusion of the study to identify biological shifts. By using this methodology, the team hopes to determine if the product influences metabolic markers during the menopausal transition.
Timeline
The Better Menopause launched in the UK in July 2023.
Two new product launches are scheduled for early 2027.
Health Landscape
The clinical trial led by the University of Southampton reflects a broader push to bring rigorous data to the menopause supplement market. This development marks an attempt to move beyond anecdotal evidence toward established clinical validation for products in this category.
While this trial is underway, it is important to remember that preliminary industry-funded research does not equate to a medical recommendation for any specific supplement. Always discuss any changes to your health regimen or the addition of new products with your physician.
The takeaway
This study highlights the ongoing effort to find evidence-based support for menopause health products. If you are experiencing metabolic changes, consult your physician to discuss evidence-backed lifestyle strategies before incorporating new supplements into your routine.
What happens next
The findings from the clinical study are expected to be published next year, providing a clearer look at the trial's outcomes.
Further reading
Explore the current research and guidance regarding metabolic changes during midlife in our Weight Loss section.
Live Poll
Do you trust that health supplements marketed for menopause provide real, verified medical benefits?
